Sex-related differences of cAMP-specific PDE4B3 mRNA in oligodendrocytes following systemic inflammation

GLIA

Volumn 60, Issue 12, 2012, Pages 1815-1825

  Johansson, Emily M ^a   Sanabra, Cristina ^a   Mengod, Guadalupe ^a  

^a INST D INVESTIGACIONS B   (Spain)

Author keywords

ICER; In situ hybridization; LPS; Multiple sclerosis; Neuroinflammation

Indexed keywords

LIPOPOLYSACCHARIDE; PHOSPHODIESTERASE 4B2; PHOSPHODIESTERASE 4B3; PHOSPHODIESTERASE IV; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL SURVIVAL; COMPARATIVE STUDY; CORPUS CALLOSUM; DOWN REGULATION; FEMALE; GENE EXPRESSION; MALE; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RNA SPLICING; SEX DIFFERENCE;

ANIMALS; CYCLIC AMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 4; FEMALE; INFLAMMATION; MALE; MICE; MICE, INBRED C57BL; OLIGODENDROGLIA; RNA, MESSENGER; SEX CHARACTERISTICS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 84867648886     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22399     Document Type: Article

References (48)

1. Ansar AS, Penhale WJ, Talal N. 1985. Sex hormones, immune responses, and autoimmune diseases. Mechanisms of sex hormone action. Am J Pathol 121: 531-551.
2. Arp J, Kirchhof MG, Baroja ML, Nazarian SH, Chau TA, Strathdee CA, Ball EH, Madrenas J. 2003. Regulation of T-cell activation by phosphodiesterase 4B2 requires its dynamic redistribution during immunological synapse formation. Mol Cell Biol 23: 8042-8057.
3. Ashdown H, Poole S, Boksa P, Luheshi GN. 2007. Interleukin-1 receptor antagonist as a modulator of gender differences in the febrile response to lipopolysaccharide in rats. Am J Physiol Regul Integr Comp Physiol 292: R1667-R1674.
4. Avni D, Ernst O, Philosoph A, Zor T. 2010. Role of CREB in modulation of TNFalpha and IL-10 expression in LPS-stimulated RAW264.7 macrophages. Mol Immunol 47: 1396-1403.
5. Banner KH, Trevethick MA. 2004. PDE4 inhibition: A novel approach for the treatment of inflammatory bowel disease. Trends Pharmacol Sci 25: 430-436.
6. Bender AT, Beavo JA. 2006. Cyclic nucleotide phosphodiesterases: Molecular regulation to clinical use. Pharmacol Rev 58: 488-520.
7. Borlikova G, Endo S. 2009. Inducible cAMP early repressor (ICER) and brain functions. Mol Neurobiol 40: 73-86.
8. Cai Z, Pang Y, Lin S, Rhodes PG. 2003. Differential roles of tumor necrosis factor-alpha and interleukin-1 beta in lipopolysaccharide-induced brain injury in the neonatal rat. Brain Res 975: 37-47.
9. Chari DM. 2007. Remyelination in multiple sclerosis. Int Rev Neurobiol 79: 589-620.
10. Conti M. 2000. Phosphodiesterases and cyclic nucleotide signaling in endocrine cells. Mol Endocrinol 14: 1317-1327.
11. Czlonkowska A, Ciesielska A, Gromadzka G, Kurkowska-Jastrzebska I. 2005. Estrogen and cytokines production-The possible cause of gender differences in neurological diseases. Curr Pharm Des 11: 1017-1030.
12. D'Sa C, Tolbert LM, Conti M, Duman RS. 2002. Regulation of cAMP-specific phosphodiesterases type 4B and 4D (PDE4) splice variants by cAMP signaling in primary cortical neurons. J Neurochem 81: 745-757.
13. D'Souza SD, Alinauskas KA, Antel JP. 1996. Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury. J Neurosci Res 43: 289-298.
14. Darnall BD, Suarez EC. 2009. Sex and gender in psychoneuroimmunology research: Past, present and future. Brain Behav Immun 23: 595-604.
15. De Vries GJ. 2004. Minireview: Sex differences in adult and developing brains: Compensation, compensation, compensation. Endocrinology 145: 1063-1068.
16. Fairweather D, Frisancho-Kiss S, Rose NR. 2008. Sex differences in autoimmune disease from a pathological perspective. Am J Pathol 173: 600-609.
17. Franklin KBJ, Paxinos G. 2007. The Mouse Brain in stereotaxic coordinates. Academic Press.
18. Gregory MS, Faunce DE, Duffner LA, Kovacs EJ. 2000. Gender difference in cell-mediated immunity after thermal injury is mediated, in part, by elevated levels of interleukin-6. J Leukoc Biol 67: 319-326.
19. Johansson EM, Sanabra C, Cortes R, Vilaro MT, Mengod G. 2011. Lipopolysaccharide administration in vivo induces differential expression of cAMP-specific phosphodiesterase 4B mRNA splice variants in the mouse brain. J Neurosci Res 89: 1761-1772.
20. Kawai T, Takeuchi O, Fujita T, Inoue J, Muhlradt PF, Sato S, Hoshino K, Akira S. 2001. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J Immunol 167: 5887-5894.
21. Kell CA, Dehghani F, Wicht H, Molina CA, Korf HW, Stehle JH. 2004. Distribution of transcription factor inducible cyclicAMP early repressor (ICER) in rodent brain and pituitary. J Comp Neurol 478: 379-394.
22. Kim JS, Bailey MJ, Ho AK, Moller M, Gaildrat P, Klein DC. 2007. Daily rhythm in pineal phosphodiesterase (PDE) activity reflects adrenergic/3', 5'-cyclic adenosine 5'-monophosphate induction of the PDE4B2 variant. Endocrinology 148: 1475-1485.
23. Klingstrom J, Lindgren T, Ahlm C. 2008. Sex-dependent differences in plasma cytokine responses to hantavirus infection. Clin Vaccine Immunol 15: 885-887.
24. Landry M, Holmberg K, Zhang X, Hokfelt T. 2000. Effect of axotomy on expression of NPY, galanin, and NPY Y1 and Y2 receptors in dorsal root ganglia and the superior cervical ganglion studied with double-labeling in situ hybridization and immunohistochemistry. Exp Neurol 162: 361-384.
25. Lehnardt S, Lachance C, Patrizi S, Lefebvre S, Follett PL, Jensen FE, Rosenberg PA, Volpe JJ, Vartanian T. 2002. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J Neurosci 22: 2478-2486.
26. Lu YC, Yeh WC, Ohashi PS. 2008. LPS/TLR4 signal transduction pathway. Cytokine 42: 145-151.
27. Marriott I, Bost KL, Huet-Hudson YM. 2006. Sexual dimorphism in expression of receptors for bacterial lipopolysaccharides in murine macrophages: A possible mechanism for gender-based differences in endotoxic shock susceptibility. J Reprod Immunol 71: 12-27.
28. McCarthy MM, Arnold AP, Ball GF, Blaustein JD, De Vries GJ. 2012. Sex differences in the brain: The not so inconvenient truth. J Neurosci 32: 2241-2247.
29. Miró X, Perez-Torres S, Artigas F, Puigdomenech P, Palacios JM, Mengod G. 2002. Regulation of cAMP phosphodiesterase mRNAs expression in rat brain by acute and chronic fluoxetine treatment. An in situ hybridization study. Neuropharmacology 43: 1148-1157.
30. Moore AR, Willoughby DA. 1995. The role of cAMP regulation in controlling inflammation. Clin Exp Immunol 101: 387-389.
31. Moreno B, Jukes JP, Vergara-Irigaray N, Errea O, Villoslada P, Perry VH, Newman TA. 2011. Systemic inflammation induces axon injury during brain inflammation. Ann Neurol 70: 932-942.
32. Murakami N, Ono T. 1987. Sex-related differences in fever development of rats. Am J Physiol 252: R284-R289.
33. Pérez-Torres S, Miró X, Palacios JM, Cortés R, Puigdoménech P, Mengod G. 2000. Phosphodiesterase type 4 isozymes expression in human brain examined by in situ hybridization histochemistry and[3H]rolipram binding autoradiography. Comparison with monkey and rat brain. J Chem Neuroanatomy 20: 349-374.
34. Pitychoutis PM, Nakamura K, Tsonis PA, Papadopoulou-Daifoti Z. 2009. Neurochemical and behavioral alterations in an inflammatory model of depression: Sex differences exposed. Neuroscience 159: 1216-1232.
35. Pompeiano M, Palacios JM, Mengod G. 1992. Distribution and cellular localization of mRNA coding for 5-HT1A receptor in the rat brain: Correlation with receptor binding. J Neurosci 12: 440-453.
36. Pottratz ST, Bellido T, Mocharla H, Crabb D, Manolagas SC. 1994. 17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism. J Clin Invest 93: 944-950.
37. Reyes-Irisarri E, Perez-Torres S, Mengod G. 2005. Neuronal expression of cAMP-specific phosphodiesterase 7b mRNA in the rat brain. Neuroscience 132: 1173-1185.
38. Reyes-Irisarri E, Perez-Torres S, Miro X, Martinez E, Puigdomenech P, Palacios JM, Mengod G. 2008. Differential distribution of PDE4B splice variant mRNAs in rat brain and the effects of systemic administration of LPS in their expression. Synapse 62: 74-79.
39. Reyes-Irisarri E, Sanchez AJ, Garcia-Merino JA, Mengod G. 2007. Selective induction of cAMP phosphodiesterase PDE4B2 expression in experimental autoimmune encephalomyelitis. J Neuropathol Exp Neurol 66: 923-931.
40. Rothe M, Wong SC, Henzel WJ, Goeddel DV. 1994. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78: 681-692.
41. Santos-Galindo M, Acaz-Fonseca E, Bellini MJ, Garcia-Segura LM. 2011. Sex differences in the inflammatory response of primary astrocytes to lipopolysaccharide. Biol Sex Differ 2: 7.
42. Schmitz GG, Walter T, Seibl R, Kessler C. 1991. Nonradioactive labeling of oligonucleotides in vitro with the hapten digoxigenin by tailing with terminal transferase. Anal Biochem 192: 222-231.
43. Schroder J, Kahlke V, Staubach KH, Zabel P, Stuber F. 1998. Gender differences in human sepsis. Arch Surg 133: 1200-1205.
44. Serrats J, Artigas F, Mengod G, Cortes R. 2003. GABAB receptor mRNA in the raphe nuclei: Co-expression with serotonin transporter and glutamic acid decarboxylase. J Neurochem 84: 743-752.
45. Srivastava S, Weitzmann MN, Cenci S, Ross FP, Adler S, Pacifici R. 1999. Estrogen decreases TNF gene expression by blocking JNK activity and the resulting production of c-Jun and JunD. J Clin Invest 104: 503-513.
46. Tomiyama M, Palacios JM, Cortes R, Vilaro MT, Mengod G. 1997. Distribution of AMPA receptor subunit mRNAs in the human basal ganglia: An in situ hybridization study. Brain Res Mol Brain Res 46: 281-289.
47. Vicini E, Conti M. 1997. Characterization of an intronic promoter of a cyclic adenosine 3', 5'-monophosphate (cAMP)-specific phosphodiesterase gene that confers hormone and cAMP inducibility. Mol Endocrinol 11: 839-850.
48. Yoshioka A, Shimizu Y, Hirose G, Kitasato H, Pleasure D. 1998. Cyclic AMP-elevating agents prevent oligodendroglial excitotoxicity. J Neurochem 70: 2416-2423.